Get started Log in

MXCT — MaxCyte Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Market Cap
£170.78m
Enterprise Value
£68.52m
Revenue
$38.63m

MaxCyte, Inc. MaxCyte, Inc. - MXCR - Clinical & Commercial Agreement with Kite
01/03/2019 07:01
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Result of Special Meeting and Issue of Equity
26/02/2019 17:32
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Results of Placing
05/02/2019 16:32
Brief: Maxcyte Has Proposed Placing To Raise A Minimum Of £10 Million
05/02/2019 07:29
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Proposed Placing to raise a minimum of £10 million
05/02/2019 07:00
Brief: Maxcyte Says FY Rev Expected To Increase About 19 Pct
15/01/2019 07:30
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Trading Update
15/01/2019 07:00
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Change of Auditor
19/12/2018 07:00
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Director Dealings
17/12/2018 18:06
Brief: Maxcyte Inc Will Consolidate Two Lines Of Common Stock
21/11/2018 08:34
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Consolidation of Trading Lines
21/11/2018 07:01
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Block Admission Six Monthly Return/TVR
20/11/2018 07:01
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Webinar: non-viral cell engineering
16/11/2018 07:00
Brief: MaxCyte Enters Into A Non-Exclusive, Clinical & Commercial License Agreement
14/11/2018 07:53
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Clinical and Commercial License Agreement
14/11/2018 07:00
Brief: MaxCyte Announces Research Agreement With Kite
12/11/2018 07:36
MaxCyte, Inc. MaxCyte, Inc. - MXCR - MaxCyte Announces Research Agreement with Kite
12/11/2018 07:00
Brief: Crispr Therapeutics And Maxcyte Expand Clinical And Commercial License Agreement Into Oncology
09/11/2018 12:06
Brief: Maxcyte, Crispr Therapeutics Expand Clinical, Commercial Oncology License Agreement
09/11/2018 07:20
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Expansion of CRISPR Commercial License Agreement
09/11/2018 07:00